Shenrong Pill
Natural health product licensed in Canada
- Licence holder
- 11753649 Canada Inc. (6 Degrees Holdings)
- NPN or DIN-HM
- 80123792
- Status
- Active licence
- Licence date
- 5 April 2023
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Cyathula officinalis K.C.Kuan: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cinnamomum aromaticum Source : Cinnamomum aromaticum - Écorce interne (tige) | 192 mg | Not calculated |
| Rehmannia glutinosa | 575 mg | Not calculated |
| Panax ginseng Source : Panax ginseng - racine | 287 mg | Not calculated |
| Morinda officinalis | 287 mg | Not calculated |
| Citrus reticulata | 144 mg | Not calculated |
| Cuscuta chinensis Source : Cuscuta Chinensis - Graine | 287 mg | Not calculated |
| Atractylodes macrocephala | 144 mg | Not calculated |
| Dioscorea oppositifolia | 287 mg | Not calculated |
| Astragalus membranaceus Source : Astragalus membranaceus - racine | 192 mg | Not calculated |
| Wolfiporia extensa | 287 mg | Not calculated |
| Cyathula officinalis | 192 mg | Not calculated |
| Cistanche tubulosa | 287 mg | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine | 287 mg | Not calculated |
| Lycium barbarum Source : Lycium barbarum - Fruit | 192 mg | Not calculated |
| Cervus elaphus | 144 mg | Not calculated |
| Paeonia lactiflora | 144 mg | Not calculated |
| Glycyrrhiza uralensis | 96 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. vulgare Source : Foeniculum vulgare subsp. vulgare var. vulgare - Seed | 144 mg | Not calculated |
Non-medicinal ingredients
Miel
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Pilule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. Panax ginseng (Ren shen) is used in traditional Chinese medicine to powerfully tonify primal qi to treat collapse of the qi, shortness of breath, cold limbs, profuse sweating and weak pulse. Panax ginseng (Ren shen) is used in traditional Chinese medicine to strengthen spleen and tonify the stomach to treat lack of energy, lack of appetite, chest and abdominal distention, and chronic diarrhea. Panax ginseng (Ren shen) is used in traditional Chinese medicine to tonify the lungs and augment qi to treat wheezing and shortness of breath. Panax ginseng (Ren shen) is used in traditional Chinese medicine to benefit heart qi and calm the spirit to treat palpitations with anxiety, insomnia, forgetfulness, and restlessness due to qi and blood deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80123792
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.